Trial Profile
A phase II, single-center, prospective, randomized, double-blind, parallel and placebo-controlled pilot clinical study to assess the efficacy and safety of NUTROPIN in combination with intensive rehabilitation in adults with spinal cord injury (SCI) and growth hormone deficiency (GHD).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Apr 2018
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Somatotropin deficiency; Spinal cord injuries
- Focus Therapeutic Use
- 25 Apr 2018 New trial record
- 20 Mar 2018 Results presented at The 100th Annual Meeting of the Endocrine Society.